Dr. Luis Sumoza on Patient Care Data From ASH
Luis Sumoza, MD, discusses the BRUIN CLL-321 study presented during the ASH Annual Meeting, highlighting the importance of this research and how it will impact patient care.
Jan 13, 2025
MEETING BRIEF
ASH 2024 – MCL
The latest news from ASH 2024 focused on mantle cell lymphoma (MCL) including abstracts, features, and helpful conference information.
Targeted and CAR-T Therapies Show Promise But Highlight Survival Challenges in TP53-Mutated MCL
Targeted and CAR-T Therapies Show Promise But Highlight Survival Challenges in TP53-Mutated MCL
A review of treatments for TP53m MCL found high response rates with targeted and CAR-T therapies but highlighted poor survival, urging innovative strategies.
Dr. Luis Sumoza on Guiding Patients & Care Teams in CLL
Dr. Luis Sumoza on Guiding Patients & Care Teams in CLL
Luis Sumoza, MD, highlights the need to explain the disease, its consequences, and treatment side effects to patients, highlighting effective communication with primary care providers is crucial to ensure coordinated care.
Optimizing Palliative Care Integration in Transplant Among Patients With Blood Cancer
Optimizing Palliative Care Integration in Transplant Among Patients With Blood Cancer
Early palliative care improves transplant patients' quality of life, especially for minoritized groups or those with high distress, suggesting targeted or clinician-led care.
Alexey Danilov, MD, PhD, on Personalized Care & Prognostic Insights in CLL
Alexey Danilov, MD, PhD, on Personalized Care & Prognostic Insights in CLL
Physician's Weekly spoke with Alexey Danilov, MD, PhD, at ASH 2024 on personalized care and prognostic insights in CLL.
Advertisement
PW QUIZ
Advertisement
Stay connected to the latest news with Physician’s Weekly
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
